Chroma Medicine highlighted data demonstrating the advantages of epigenetic editing for multiplex gene regulation at the American Society of Gene & Cell Therapy (ASGCT) 26 th Annual Meeting in Los ...
WALTHAM, Mass.--(BUSINESS WIRE)--SeQure Dx, a cutting-edge gene editing diagnostics company, has announced its emergence from stealth mode with an aim to partner with biopharma companies developing ...
Scientists have worked tirelessly to develop ever more precise and efficient CRISPR-Cas systems to reach the ultimate goal: safe and effective CRISPR-Cas-based medical treatments. Over the years, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results